Skip to main content

MoneyWorks4Me

Aurobindo Pharma reports 33% rise in Q2 consolidated net profit

05 Nov 2026 Evaluate

Aurobindo Pharma has reported its results for the second quarter ended September 30, 2026 (Q2FY27).

The company has reported a 24.46% rise in its net profit at Rs 723.58 crore for the quarter ended September 30, 2026, as compared to Rs 581.37 crore for the same quarter in the previous year. Total income increased by 13.52% to Rs 3,280.13 crore for Q2FY27 as compared to Rs 2,889.45 crore for the corresponding quarter of the previous year.

On a consolidated basis, the company has reported a 32.72% rise in its net profit at Rs 1,126.08 crore for Q2FY27, as compared to Rs 848.45 crore for the same quarter in the previous year. Total income increased by 24.09% to Rs 10,431.51 crore for Q2FY27 as compared to Rs 8,406.29 crore for the corresponding quarter of the previous year.


Peers
Company Name CMP
Sun Pharma. Inds. 1872.30
Dr. Reddys Labs. 1396.00
Cipla 1420.00
Lupin 1968.95
Zydus Lifesciences 1195.00
View more..